Wealth Enhancement Trust Services’s Lifestance Health LFST Stock Holding History

Wealth Enhancement Trust Services’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$589	Buy	+55	New	+$425	﹤0.01%	1216

Other funds holding LFST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Wealth Enhancement Trust Services's LFST Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Lifestance Health (LFST) in Q2 2026: 55 shares worth $589. The stake represents ﹤0.01% of the portfolio and ranks #1216 among its holdings.

184 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Wealth Enhancement Trust Services held 55 shares of Lifestance Health worth $589 as of Q2 2026.
Lifestance Health was a new Wealth Enhancement Trust Services position in Q2 2026.
Lifestance Health made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1216 holding.
184 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.